[{"address1": "4370 La Jolla Village Drive", "address2": "Suite 1050", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 225 7696", "website": "https://aardvarktherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Tien-Li  Lee M.D.", "age": 50, "title": "CEO, Secretary & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 703099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.28, "open": 12.18, "dayLow": 12.0, "dayHigh": 12.52, "regularMarketPreviousClose": 12.28, "regularMarketOpen": 12.18, "regularMarketDayLow": 12.0, "regularMarketDayHigh": 12.52, "payoutRatio": 0.0, "forwardPE": -3.371516, "volume": 66266, "regularMarketVolume": 66266, "averageVolume": 203371, "averageVolume10days": 139700, "averageDailyVolume10Day": 139700, "bid": 11.99, "ask": 12.15, "bidSize": 1, "askSize": 1, "marketCap": 263456592, "fiftyTwoWeekLow": 4.88, "fiftyTwoWeekHigh": 19.58, "allTimeHigh": 19.58, "allTimeLow": 4.88, "fiftyDayAverage": 13.7319, "twoHundredDayAverage": 12.051125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 137651584, "profitMargins": 0.0, "floatShares": 11102845, "sharesOutstanding": 21773272, "sharesShort": 1774753, "sharesShortPriorMonth": 1668754, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.081499994, "heldPercentInsiders": 0.14552, "heldPercentInstitutions": 0.59603, "shortRatio": 10.03, "shortPercentOfFloat": 0.125, "impliedSharesOutstanding": 21773272, "bookValue": 5.628, "priceToBook": 2.1499646, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -48772000, "trailingEps": -2.53, "forwardEps": -3.58889, "enterpriseToEbitda": -2.576, "52WeekChange": -0.09439528, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 12.1, "targetHighPrice": 50.0, "targetLowPrice": 18.0, "targetMeanPrice": 32.63636, "targetMedianPrice": 32.0, "recommendationMean": 1.18182, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 126350000, "totalCashPerShare": 5.803, "ebitda": -53437000, "totalDebt": 545000, "quickRatio": 11.769, "currentRatio": 12.035, "debtToEquity": 0.445, "returnOnAssets": -0.30806, "returnOnEquity": -0.48061, "freeCashflow": -25479376, "operatingCashflow": -45089000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AARD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1771017004, "regularMarketTime": 1771016402, "exchange": "NMS", "messageBoardId": "finmb_614979892", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.46579, "regularMarketPrice": 12.1, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1739457000000, "postMarketChangePercent": 0.0, "postMarketPrice": 12.1, "postMarketChange": 0.0, "regularMarketChange": -0.179999, "regularMarketDayRange": "12.0 - 12.52", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 203371, "fiftyTwoWeekLowChange": 7.2200003, "fiftyTwoWeekLowChangePercent": 1.4795082, "fiftyTwoWeekRange": "4.88 - 19.58", "fiftyTwoWeekHighChange": -7.4799995, "fiftyTwoWeekHighChangePercent": -0.38202244, "fiftyTwoWeekChangePercent": -9.4395275, "shortName": "Aardvark Therapeutics, Inc.", "longName": "Aardvark Therapeutics, Inc.", "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.53, "epsForward": -3.58889, "epsCurrentYear": -2.95111, "priceEpsCurrentYear": -4.1001525, "fiftyDayAverageChange": -1.6318998, "fiftyDayAverageChangePercent": -0.11884006, "twoHundredDayAverageChange": 0.04887581, "twoHundredDayAverageChangePercent": 0.0040557054, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Aardvark Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]